United BioPharma (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Taiwan. The platform will be used to build late-stage clinical and commercial production capacity for biopharmaceuticals. Read more


As part of the agreement, BMS and Ono will jointly develop and commercialise Opdivo (nivolumab) and Yervoy (ipilimumab) across a broad range of tumour types. Read more